ArticleFrontiers in pharmacology2026

SGLT2 inhibitors and outcomes in the chronic Post-LVAD phase: a multicenter real-world cohort study.

Jheng-Yan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.